Our lab combines cutting edge next-generation sequencing, computational analysis, and experimental work to decipher the role of epigenetic modification, focusing on DNA methylation and cellular phenotype in disease, particularly in cancer.
Our laboratory's dream is to assign function to every single methylation change that could possibly occur in a cell so that ultimately epigenetic changes could be used to predict and prevent disease.
We are extremely grateful to our funders who enable us to do our work.
The Chatterjee lab is primarily funded by a Rutherford Discovery Fellowship from Te Apārangi the Royal Society of New Zealand
- Learn more about the Rutherford Discovery Fellowship
- Read more about Te Apārangi the Royal Society of New Zealand
Other funding partnerships
- Cancer Research Trust
- Dunedin School of Medicine research grants
- Lottery Health
- Marsden Fund
- The Maurice and Phyllis Paykel Trust
- Ministry of Business, Innovation and Employment (MBIE)
- New Zealand Institute for Cancer Research Trust
- University of Otago